USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
Linda Lee, senior research scientist at C4 Therapeutics, describes how lab equipment reviews help to accelerate scientific progress
Protein Metrics’ software solutions complement Thermo Fisher’s mass spectrometry systems to facilitate precise, reliable data processing and drive innovation
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
A novel machine learning method called DeepBAR could accelerate drug discovery and protein engineering
The monthly safety report will be made public on the European Medicines Agency website
Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19
SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses
Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a human cell component involved in viral replication
The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process
For the chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new product which has made the most difference to your research
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
Companion diagnostic can help guide treatment decisions in cases of NSCLC
Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Focusing on innate immunity opens way for precision medicine approaches to AD
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
New PhenoVue™ cell painting reagent kit makes the process of “painting” cells easier for research scientists by providing carefully selected and pre-optimized reagents
Researchers have developed a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
AstraZeneca, Exactmer, Novartis and UK Research & Innovation aim to make the UK the first country in the world to deliver this pioneering production process at a large scale